Alyeska Investment Group, L.P. Applied Therapeutics Inc. Call Options Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$2.25 - $7.4 $7.88 Million - $25.9 Million	-3,500,000 Reduced 46.67%	4,000,000 $27.2 Million
Q2 2023 Aug 14, 2023	BUY	$0.77 - $1.8 $2.5 Million - $5.85 Million	3,250,000 Added 76.47%	7,500,000 $9.6 Million
Q1 2023 May 15, 2023	BUY	$0.75 - $1.21 $3.19 Million - $5.14 Million	4,250,000 New	4,250,000 $3.44 Million
Q3 2022 Nov 14, 2022	BUY	$0.86 - $1.55 $3.66 Million - $6.59 Million	4,250,000 New	4,250,000 $3.95 Million

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $30.7M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.